For decades, the belief has circulated that a daily glass of wine may contribute to a longer and

healthier life. Wine—particularly red wine—has been considered a “heart ally,” as it has been

associated with a lower incidence of heart attacks and strokes. Given that cardiovascular diseases

remain the leading cause of death worldwide, this supposed protective effect has attracted

significant scientific interest. But to what extent is it supported by evidence?

 

Origins of the Belief

 

The link between wine and health gained popularity with the so-called French Paradox: the

observation that the French population exhibited low cardiovascular mortality despite consuming

a diet rich in saturated fats. This phenomenon was partially attributed to the regular and moderate

consumption of red wine.

Additionally, wine is part of the Mediterranean diet, widely recognized for its association with

health and longevity. This further reinforced the idea that wine, within a balanced dietary pattern,

could exert beneficial effects on the body.

 

Proposed Biological Mechanisms

 

Wine, especially red wine, contains bioactive compounds such as polyphenols, flavonoids

(including anthocyanins), and stilbenes (notably resveratrol), known for their antioxidant

activity. Experimental studies in vitro and in animal models have explored possible mechanisms:

• Resveratrol and sirtuins: Resveratrol appears to activate sirtuins, proteins that regulate metabolism, cellular repair, and aging. These enzymes are involved in pathways related to longevity and cellular stress response.
• Antioxidant activity and inflammation: Polyphenols neutralize reactive oxygen species (ROS)—highly reactive oxygen-derived molecules associated with cellular damage—thereby reducing inflammation and protecting vascular endothelium.
• Effects on gut microbiota: Recent research suggests that wine phenolic compounds may modulate intestinal microbial diversity, with potentially favorable systemic effects.
• Synergy of compounds: Antioxidant effects may depend on the combination of multiple polyphenols rather than a single isolated component.

While these findings are promising, they are primarily derived from experimental models and do

not guarantee equivalent effects in humans.

 

Evidence in Humans

 

The available human evidence largely comes from observational studies rather than prospective

double-blind trials. Some epidemiological studies have explored the relationship between

moderate wine consumption and mortality or cardiovascular morbidity:

• The study “Wine Consumption and 20-Year Mortality Among Late-Life Adults” found that moderate wine consumption was associated with lower long-term mortality, although the authors emphasized the difficulty of isolating the effect of wine from other lifestyle factors.
• The narrative review “Moderate Wine Consumption and Health” (2022) reported a 20–24% reduction in overall mortality among moderate drinkers but highlighted the influence of confounding variables (diet, socioeconomic status, smoking).
• The article “Wine: An Aspiring Agent in Promoting Longevity and Preventing Disease” identified positive associations with reduced risk of metabolic syndrome, cognitive decline, and certain cancers.
• In contrast, a meta-analysis published in JAMA Network Open (2023) concluded that, after adjusting for biases (such as including former drinkers in the abstainer group), low or moderate alcohol consumption showed no significant association with reduced overall mortality.
• Finally, a prospective study involving 800 older adults found no relationship between urinary resveratrol metabolites and longevity, suggesting that dietary intake of this compound may have a limited contribution.

Taken together, these findings indicate favorable biological signals, although the magnitude and

direct impact in humans remain uncertain.

 

Limitations of Current Evidence

 

Despite encouraging results, several limitations exist:

1. Lack of long-term clinical trials: Most studies are observational and therefore do not establish causality.
2. Confounding factors: Moderate wine drinkers often have healthier diets, higher education levels, and fewer harmful habits, which may bias results.
3. “Former drinker” bias: Individuals who stop drinking for medical reasons are often classified as abstainers, distorting comparisons.
4. Measurement of consumption: Self-reported drinking habits introduce errors and variability over time.
5. Population variability: Potential benefits appear to diminish in older adults or individuals with chronic diseases.

Moreover, the risks associated with alcohol—even at moderate levels—are well documented:

increased risk of cancer (including breast cancer), liver disease, dependence, obesity, and

metabolic disorders. In 2023, the World Health Organization (WHO) officially stated that there is

no safe level of alcohol consumption, emphasizing that any amount consumed is potentially

harmful.

 

Interpretation and Conclusions

 

Current evidence suggests that wine may have conditional benefits linked to its polyphenol

content, and that moderate consumption is associated with dietary balance and healthy lifestyle

patterns. However, these benefits do not justify initiating alcohol consumption for preventive

purposes, nor do they guarantee a meaningful impact on longevity.

Wine should not be considered a health source or a strategy for life extension, but rather—at

best—a cultural and gastronomic component compatible with a healthy lifestyle when consumed

in moderation.

For those who already include it in their diet, general recommendations (one glass per day for

women, up to two for men) remain a reasonable guideline. In vulnerable populations—such as

individuals with liver disease, cardiovascular conditions, cancer, or a history of

addiction—consumption should be avoided or strictly limited.

Ultimately, the relationship between wine and longevity lies in a middle ground: it is neither a

complete myth nor a scientifically confirmed reality. Future research, based on controlled trials

and precise biomarkers, will help clarify whether wine can truly be considered a protective factor

or simply a moderate pleasure within a healthy lifestyle.

 

References

 

• Bonkowski, M. S., & Sinclair, D. A. (2016). Slowing ageing by design: The rise of NAD⁺ and

sirtuin-activating compounds. Nature Reviews Molecular Cell Biology, 17(11), 679–690.

https://doi.org/10.1038/nrm.2016.93

• Forman, H. J., Zhang, H., & Rinna, A. (2014). Glutathione: Overview of its protective roles

and measurement methods. Free Radical Biology and Medicine, 66, 193–205.

https://doi.org/10.1016/j.freeradbiomed.2013.08.013

• Guarente, L. (2013). Sirtuins and aging: An update. Nature Reviews Molecular Cell Biology,

14(8), 543–548. https://doi.org/10.1038/nrm3604

• Haigis, M. C., & Sinclair, D. A. (2010). Mammalian sirtuins: Biological insights and disease

relevance. Annual Review of Pathology: Mechanisms of Disease, 5, 253–295.

https://doi.org/10.1146/annurev.pathol.4.110807.092250

• Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G.,

Cacciatore, F., Bonaduce, D., & Abete, P. (2018). Oxidative stress, aging, and diseases. Clinical

Interventions in Aging, 13, 757–772. https://doi.org/10.2147/CIA.S158513

• Rodrigo, R., Miranda, A., & Vergara, L. (2011). Red wine polyphenols and cardiovascular

disease: A critical update. Biological Research, 44(3), 179–187. https://doi.org/10.4067/S0716-

97602011000300001

• Sies, H. (2015). Oxidative stress: Concept and some practical aspects. Antioxidants, 4(2),

253–259. https://doi.org/10.3390/antiox4020253

• Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H.,

Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., Moonen-Kornips, E., Hesselink, M. K. C.,

Kunz, I., Schrauwen-Hinderling, V. B., Blaak, E. E., Auwerx, J., & Schrauwen, P. (2012).

Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism

and metabolic profile in obese humans. Cell Metabolism, 14(5), 612–622.

https://doi.org/10.1016/j.cmet.2011.10.002

• Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007). Free

radicals and antioxidants in normal physiological functions and human disease. International

Journal of Biochemistry & Cell Biology, 39(1), 44–84.

https://doi.org/10.1016/j.biocel.2006.07.001

• Arranz, S., Chiva-Blanch, G., Valderas-Martínez, P., Medina-Remón, A., Lamuela-Raventós,

R. M., & Estruch, R. (2012). Wine, beer, alcohol and polyphenols on cardiovascular disease and

cancer. Nutrients, 4(7), 759–781. https://doi.org/10.3390/nu4070759

• Di Renzo, L., Cioccoloni, G., Gratteri, S., Cammarano, A., Schiavoni, M., Giacchi, E., De

Lorenzo, A., & Carruba, G. (2021). Moderate red wine consumption increases the expression of

key longevity-related genes and improves metabolic health in humans. Molecules, 26(4), 1005.

https://doi.org/10.3390/molecules26041005

• Mukamal, K. J., Kuller, L. H., Fitzpatrick, A. L., Longstreth, W. T. Jr., & Mittleman, M. A.

(2007). Wine consumption and 20-year mortality among older adults. American Journal of

Clinical Nutrition, 85(4), 875–882. https://doi.org/10.1093/ajcn/85.4.875

• Pérez-Martín, M., Pérez-Martín, J., & Blázquez, M. (2022). Moderate wine consumption and

health: A narrative review. Nutrients, 14(1), 135. https://doi.org/10.3390/nu14010135

• González-Casado, I., García-Esquinas, E., López-García, E., Rodríguez-Artalejo, F., &

Ordovás, J. M. (2024). Wine: An aspiring agent in promoting longevity and preventing disease.

Nutrients, 16(5), 982. https://doi.org/10.3390/nu16050982

• Zhao, J., Stockwell, T., Roemer, A., & Chikritzhs, T. (2023). Association between daily alcohol

intake and risk of all-cause mortality: A systematic review and meta-analysis. JAMA Network

Open, 6(3), e230295. https://doi.org/10.1001/jamanetworkopen.2023.0295

• Semba, R. D., Ferrucci, L., Bartali, B., Urpi-Sarda, M., Zamora-Ros, R., Sun, K., Cherubini,

A., Bandinelli, S., Andres-Lacueva, C., & Resnick, S. M. (2014). Resveratrol levels and all-

cause mortality in older community-dwelling adults. JAMA Internal Medicine, 174(7),

1077–1084. https://doi.org/10.1001/jamainternmed.2014.1582

• Rodrigo, R., Gil-Becerra, J., & Prieto, J. C. (2018). Polyphenols, oxidative stress, and human

health: A review of the evidence. Antioxidants, 7(11), 161.

https://doi.org/10.3390/antiox7110161